Olmesartan/Amlodipine Tablets 5/20 mg

Adult dose

This medication is administered once daily, 1 tablet, with or without food, preferably at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20 mg: Administered to patients whose blood pressure is not adequately controlled by monotherapy with amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: Administered as monotherapy with olmesartan medoxomil 20 mg.

Child dose

Safety and efficacy for pediatric patients under 18 years of age have not been established.

This medication can cause serious damage or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so discontinuation is required immediately upon confirmation of pregnancy. It should not be used in individuals with allergies to the active ingredients or similar compounds, those who are pregnant or breastfeeding, individuals with severe liver disease, heart valve disease, biliary obstruction, patients undergoing kidney dialysis, patients in shock, and certain diabetic patients. Patients with deficient fluid or salt may experience hypotension, so they should be closely monitored when starting this medication, and care should be taken as rapid vasodilation may also lead to hypotension. Caution is advised when administering to patients with weakened cardiac or kidney function, obstructive coronary artery disease, congestive heart failure, and those with reduced liver function. Various side effects such as dizziness, headache, hypotension, palpitations, dyspepsia, rash, and edema may occur; any abnormal symptoms should prompt immediate consultation with a medical professional. This medication may lower blood pressure, so when used in conjunction with other antihypertensive medications, careful monitoring of blood pressure, kidney function, and electrolyte status is necessary, and interactions may occur with certain drugs, which should be disclosed. This medication should not be taken during pregnancy, and if breastfeeding, caution is required as it may be excreted in breast milk and affect the infant, thus breastfeeding should be discontinued or medication should be stopped. Safety and efficacy have not been established for children under 18 years of age, and it is not recommended for them. Elderly patients may have reduced kidney and liver function, so treatment should start with a low dose and be approached cautiously. In the case of overdose, hypotension and cardiac function abnormalities may occur, requiring immediate medical attention, and treatment to raise blood pressure may be necessary if hypotension is severe. This medication should be stored away from direct sunlight and moisture, out of reach of children, and it is advisable not to transfer it to a different container.

Serious side effects

Urticaria, severe swelling (edema), difficulty breathing, respiratory distress, angioedema, pain in mucous membranes of mouth/eyes, severe allergic reactions, severe skin reactions, liver abnormalities (jaundice), serious neurological symptoms (dizziness, fainting), severe edema or urination abnormalities (acute renal failure, markedly reduced urine output, elevated serum creatinine), angioedema, autoimmune hepatitis

Mild side effects

• Dizziness
• headache
• orthostatic hypotension
• drowsiness
• paresthesia
• decreased sensation
• fainting
• vertigo
• palpitations
• rapid heartbeat

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication for a long time.

Appearance

White round film-coated tablets

Package unit

30 tablets/PTP[((10 tablets/PTP) x 3)]